NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
53 hedge funds and large institutions have $49M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
53
Holding in Top 10
–
Calls
$17K
Puts
–
Top Buyers
| 1 | +$2.17M | |
| 2 | +$416K | |
| 3 | +$288K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$278K |
| 5 |
JPMorgan Chase & Co
New York
|
+$268K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$939K | |
| 3 | -$324K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$236K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$224K |